Skip to main content
. 2020 Sep 16;21(18):6795. doi: 10.3390/ijms21186795

Figure 6.

Figure 6

Level of cfDNA (ng/mL) in supernatants obtained after 1h neutrophils, from healthy subjects (n = 14) and psoriatic patients (n = 28), incubation with LPS, cannabidiol and LPS with cannabidiol. a—statistically significant difference between neutrophils from patients with psoriasis vulgaris and healthy subjects p < 0.05; x—statistically significant difference between treated neutrophils (with LPS, CBD, or LPS + CBD) and non-treated (control) cells; p < 0.05; z—statistically significant difference between neutrophils treated with LPS + CBD and treated only with LPS; p < 0.05.